“…Mu50 and its putative precursor strain Mu3, designated hetero-VRSA (16), have increased cell wall synthesis. When compared with vancomycin-susceptible control strains, they have enhanced incorporation of N-acetylglucosamine (GlcNAc) into the cell wall, an increased pool size of the cytoplasmic murein monomer precursor (UDP-N-acetylmuramyl-pentapeptide), an increased cell wall turnover rate as measured by the release of radiolabeled cell wall materials, and increased production of penicillin-binding proteins 2 and 2Ј (11,12,14,17). In addition to these common features with hetero-VRSA strain Mu3, VRSA strain Mu50 displays about a twofold increase in cell wall thickness, slower release of cell wall mate-rial, and an increased proportion of glutamine-nonamidated muropeptides in its cell wall (11,12).…”